-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PHmjvNPN0Db6fpI92x1JNrjrjfLNrkpfkNnUSCOGMpRT7qwnbYlAm4IV/cBVQ28n 7zTjVS8ESkH32foJJXp53g== 0001181431-07-034510.txt : 20070522 0001181431-07-034510.hdr.sgml : 20070522 20070522164837 ACCESSION NUMBER: 0001181431-07-034510 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070522 FILED AS OF DATE: 20070522 DATE AS OF CHANGE: 20070522 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: NIBLACK JOHN F CENTRAL INDEX KEY: 0001174456 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12400 FILM NUMBER: 07871602 BUSINESS ADDRESS: STREET 1: C/O PFIZER INC STREET 2: 235 EAST 42ND ST ATTN: CORPORATE SEC CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 2127334802 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INCYTE CORP CENTRAL INDEX KEY: 0000879169 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 943136539 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ROUTE 141 & HENRY CLAY ROAD STREET 2: BUILDING E336 CITY: WILMINGTON STATE: DE ZIP: 19880 BUSINESS PHONE: 3024986700 MAIL ADDRESS: STREET 1: ROUTE 141 & HENRY CLAY ROAD STREET 2: BUILDING E336 CITY: WILMINGTON STATE: DE ZIP: 19880 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE CORP DATE OF NAME CHANGE: 20030318 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE GENOMICS INC DATE OF NAME CHANGE: 20000710 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930902 4 1 rrd156332.xml X0202 4 2007-05-22 0 0000879169 INCYTE CORP INCY 0001174456 NIBLACK JOHN F EXPERIMENTAL STATION ROUTE 141 & HENRY CLAY ROAD WILMINGTON DE 19880 1 0 0 0 Non-Qualified Stock Options (right to buy) 7.26 2007-05-22 4 A 0 20000 0 A 2008-05-22 2017-05-21 Common Stock 20000 20000 D This option vests in full on the first anniversary of the date of grant or, if earlier, the date of the next regular annual meeting of the Company's stockholders or upon change of control (as defined in option plan). /s/ John F. Niblack 2007-05-22 -----END PRIVACY-ENHANCED MESSAGE-----